537
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Ocular Manifestations of Sickle Cell Disease: Signs, Symptoms and Complications

ORCID Icon, ORCID Icon, , , &
Pages 259-264 | Received 26 Sep 2019, Accepted 23 Jan 2020, Published online: 03 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Saif Aldeen AlRyalat, Bahaa Al-Din Mustafa Jaber, Abdulaziz A. Alzarea, Abdullah A. Alzarea, Wejdan A. alosaimi & Mouna Al Saad. (2021) Ocular Manifestations of Sickle Cell Disease in Different Genotypes. Ophthalmic Epidemiology 28:3, pages 185-190.
Read now

Articles from other publishers (8)

Mohammed B. Nawaiseh, Ahmed M. Yassin, Mohammed Q. Al-Sabbagh, Ahmad AlNawaiseh, Hadil Zureigat, Dina Aljbour AlMajali, Rund R. Haddadin, Mohammad El-Ghanem & Mohammad Abu-Rub. (2024) Abnormal Neurologic Findings in Patients With Sickle Cell Disease Without a History of Major Neurologic Events. Neurology Clinical Practice 14:1.
Crossref
Ng'weina F. Magitta, Francisca B. Komanya, Baraka O. Alphonce, Mbelwa D. Bitesigilwe, Emmanuel M. Sindato & John R. Meda. (2023) Acute soft head syndrome in a teenager with sickle cell anemia: A case report. Clinical Case Reports 11:11.
Crossref
Victor de Haidar e Bertozzo, Sueli Matilde da Silva Costa, Mirta Tomie Ito, Pedro Rodrigues Sousa da Cruz, Bruno Batista Souza, Vinicius Mandolesi Rios, Marina Gonçalves Monteiro Viturino, Júlia Nicoliello Pereira de Castro, Thiago Adalton Rosa Rodrigues, Carolina Lanaro, Dulcinéia Martins de Albuquerque, Roberta Casagrande Saez, Sara Teresinha Olalla Saad, Margareth Castro Ozelo, Fernando Ferreira Costa & Mônica Barbosa de Melo. (2023) Comparative transcriptome analysis of endothelial progenitor cells of HbSS patients with and without proliferative retinopathy. Experimental Biology and Medicine 248:8, pages 677-684.
Crossref
Mohammed Nawaiseh, Allaa Roto, Yara Nawaiseh, Mohammad Salameh, Rund Haddadin, Lana Mango, Hussam Nawaiseh, Doha Alsaraireh, Qais Nawaiseh, Saif Aldeen AlRyalat, Amer Alwreikat, David J. Ramsey & Nakhleh Abu-Yaghi. (2022) Risk factors associated with sickle cell retinopathy: findings from the Cooperative Study of Sickle Cell Disease. International Journal of Retina and Vitreous 8:1.
Crossref
Khadija Al Saif, Fatema Mohamed Abdulla, Anwaar Alrahim, Sara Abduljawad, Zainab Matrook, Jenan Jaafar Abdulla, Fatima Bughamar, Fatema Alasfoor, Rana Taqi, Amna Almarzooq & Jamil Ahmed. (2022) Caregivers’ experience of seeking care for adolescents with sickle cell disease in a tertiary care hospital in Bahrain. PLOS ONE 17:4, pages e0266501.
Crossref
Wen-Qing Shi, Ting Han, Ren Liu, Qiang Xia, Tian Xu, Yan Wang, Shuang Cai, Shui-Lin Luo, Yi Shao & Rui Wu. (2021) Retinal Microvasculature and Conjunctival Vessel Alterations in Patients With Systemic Lupus Erythematosus—An Optical Coherence Tomography Angiography Study. Frontiers in Medicine 8.
Crossref
Benoît Mbiya Mukinayi, John Mpoyi Kalenda, Didier Kalombo Kalenda, Ghislain Disashi Tumba & Béatrice Gulbis. (2021) Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report. Journal of Medical Case Reports 15:1.
Crossref
TunjiS Oluleye, YewandeOlubunmi Babalola, OluwoleIyiola Majekodunmi & ModupeA Ijaduola. (2021) Sickle cell retinopathy: Patient awareness, mode of presentation, and treatment modalities in Ibadan, South-West Nigeria. Nigerian Journal of Medicine 30:5, pages 481.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.